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Liver ischemia-reperfusion injury is a major cause of primary graft non-function or initial function failure post-transplantation.
In this study, we examined the eﬀects of sodium nitrite supplementation on liver IRI in either Lactated Ringer’s (LR) solution or
University of Wisconsin (UW) solution. The syngeneic recipients of liver grafts were also treated with or without nitrite by intra-
peritoneal injection. Liver AST and LDH release were signiﬁcantly reduced in both nitrite-supplemented LR and UW preservation
solutions compared to their controls. The protective eﬀect of nitrite was more eﬃcacious with longer cold preservation times.
Liver histological examination demonstrated better preserved morphology and architecture with nitrite treatment. Hepatocellular
apoptosis was signiﬁcantly reduced in the nitrite-treated livers compared their controls. Moreover, liver grafts with extended cold
preservation time of 12 to 24 hours demonstrated improved liver tissue histology and function post-reperfusion with either the
nitrite-supplementedpreservationsolutionorinnitrite-treatedrecipients.Interestingly,combinedtreatmentofboththelivergraft
and recipient did not confer protection. Thus, nitrite treatment aﬀords signiﬁcant protection from cold ischemic and reperfusion
injury to donor livers and improves liver graft acute function post-transplantation. The results from this study further support the
potential for nitrite therapy to mitigate ischemia-reperfusion injury in solid organ transplantation.
1.Introduction
Liver ischemia-reperfusion injury (IRI) is a major cause
of primary graft nonfunction or initial function failure
posttransplantation, both of which can ultimately lead to
acute and/or chronic rejection. Moreover, the occurrence of
signiﬁcant IRI in marginal liver donors serves to limit the
number of organs available for transplantation. Therefore,
insights into therapies targeted toward attenuating liver IRI
should assist in thwarting liver graft primary nonfunction
or poor function, reduce the episodes of acute and chronic
graftrejection,extendtheusageofmarginaldonors,andthus
aid in reducing the donor organ shortage. Interestingly, to
date, clinically translatable mechanisms of liver IR have not
yet been well characterized, resulting in a paucity of available
therapies for prevention and treatment of liver IRI.
Nitric oxide (NO) is a free radical produced from L-
arginine and is a versatile signaling mediator involved in
a multitude of critical cellular events [1]. NO is also an
important eﬀector molecule produced by macrophage and
dendritic cells (DCs) that is involved in immune regulation
and host innate and adaptive immunity [2, 3]. NO has
been found to attenuate liver IRI during transplantation
through various mechanisms including reducing hepatocel-
lular apoptosis and inﬂammatory tissue injury [4]. More
recently, inhaled NO administered to human liver transplant
recipients prior to transplantation and continued through-
out the entire operative procedure signiﬁcantly accelerated2 Journal of Transplantation
restoration of liver function by decreasing hepatocyte apop-
tosis [5]. While the underlying mechanisms of inhaled NO
on liver IRI are largely unknown, the possibility of the
anion nitrite, an oxidative product of NO metabolism that
is increased in the circulation with NO breathing, playing
a role has been suggested. Consistent with this concept,
sodium nitrite has been shown to limit acute IRI in both
murine heart and liver of warm IR and is associated with
decreased incidence of myocardial infarction and hepatocyte
apoptosis [6]. Underlying this protection are biochemical
pathways that couple ischemia to nitrite reduction to NO,
which then can mediate cytoprotective eﬀects by multiple
possible mechanisms [7–10]. Similarly, nitrite-dependent
protection has been observed in other models of ischemic
tissue injury encompassing all major organ systems [11].
In this study, we critically examined the protective eﬀects
of nitrite administration on liver IRI in a cold murine
IRI model using diﬀerent preservation solutions. Our study
demonstrates that nitrite supplementation of either Lactated
Ringer’s (LR) or University of Wisconsin’s (UW) solutions
signiﬁcantly reduced liver cold IR injury and protected
hepatocytes from apoptosis posttransplantation.
2.MaterialsandMethods
2.1. Animals. Male C57BL/10 (B10; H2b) and C57BL/10
(C3H; H2k) mice, 10–12 weeks of age (The Jackson Lab-
oratory, Bar Harbor, ME), were maintained in a speciﬁc
pathogen-free facility of the University of Washington Medi-
cal Center. The mice were provided with Purina rodent chow
andtapwateradlibitum.Animalcarewasincompliancewith
ourinstitutionalanimalcareanduseofcommittee-approved
protocol, and with the “Guide for the Care and the Use of
Laboratory Animals” published by the National Institutes of
Health.
2.2. Reagents. Sodium nitrite was purchased from Sigma-
Aldrich (cat no. S-2252, St. Louis, MO). UW solution
was obtained from Life Center Northwest (Bellevue, WA,
manufactured by Duramed Pharmaceuticals, Inc, Cincin-
nati, OH), and LR solution was from Baxter Healthcare
Corporation (Deerﬁeld, IL). ApopTag Peroxidase In Situ
Apoptosis Detection Kit was from Millipore Corporation
(Billerica, MA).
2.3. Nitrite Treatment Protocol. The livers were ﬂushed via
the portal vein with 5mL of either cold LR or UW solution
containing 20 units/mL heparin with or without sodium
nitrite supplementation of 25–250µM and then were pro-
curedandstoredinasterilecontainercontaining2mL(equal
mouse total body blood volume) perfusion solution for
diﬀerent time periods, from 1 hour to 48 hours, respectively.
AST and LDH enzyme release from the preservants and
the liver histology were examined at diﬀerent time points.
The time course curves were analyzed to determine the
optimal concentration of nitrite. The livers preserved in
the UW solution with or without nitrite supplementation
were transplanted into syngeneic recipients after either 12
or 24 hours of cold preservation, respectively. The recipients
of syngeneic liver grafts also received either sodium nitrite
250µmol in 2mL total blood volume ﬁnal concentration or
equal amounts of phosphorus buﬀer solution (PBS) by i.p.
injection just prior to liver transplantation. Liver tissue was
obtainedforhistologyandapoptosisassaysat10minutesand
3h o u r s ,r e s p e c t i v e l y .
2.4. Liver Enzyme Assays. Samples from the liver preservants
at 1, 6, and 12 hours in LR solution and 12, 24, and 48 hours
in UW solution with the concentration range of nitrite from
0.25µM to 1000µm were assayed for ALT, AST, and LDH
levels using a spectrophotometric method, respectively. The
LRandUWsolutionswithoutanionnitritesupplementation
were used as controls.
2.5. Liver Transplantation. Orthotopic liver transplantation
(OLTx) with revascularization accomplished with a combi-
nation of suture and cuﬀ techniques was performed between
syngeneic strain combinations as described [3, 12]. Donor
livers were preserved in the UW solution at extended times
of 12 and 24 hours, with or without nitrite supplementation
at 25 or 125µM, respectively. Liver biopsy was performed at
10 minutes and 3 hours postreperfusion, respectively.
2.6. Histological Analysis. Formalin-stored tissue specimens
were embedded in paraﬃn and cut into 4mm sections
and then were examined by routine hematoxylin and eosin
staining. Three samples from each group were analyzed
under 10 high-power ﬁelds. The histology scores of liver
tissue sections were determined by 2 independent persons in
a blind manner according to the following scoring criteria:
0, no hepatocellular damage; (1) mild injury characterized
by cytoplasmic vacuolization and focal nuclear pyknosis; (2)
moderate injury with dilated sinusoids, cytosolic vacuoliza-
tion, and blurring of intercellular borders; (3) moderate to
severe injury with coagulative necrosis, abundant sinusoidal
dilation,redbloodcellextravasationintohepaticchords,and
hypereosinophiliaandmarginationofneutrophils;(4)severe
necrosis with loss of hepatic architecture, disintegration
of hepatic cords, hemorrhage, and neutrophil inﬁltration.
Criteria to speciﬁcally evaluate peripheral mononuclear cell
inﬁltration ((0) zero; (1) minimal; (2) mild; (3) moderate;
(4) severe) were also used (Lang 2007).
2.7. TUNEL Staining. Apoptotic cells in frozen sections
(4µm) were identiﬁed using the ApopTag Peroxidase In Situ
Apoptosis Detection Kit (Millipore Corporation, Bilerica,
MA) and followed according to the manufacturer’s instruc-
tions, as described by (Li, 2008). Cryosections (4µm) were
mounted on precleaned slides, air-dried overnight at room
temperature (RT), and then ﬁxed for 10min at RT in 10%
neutral buﬀered formalin (pH 7.4), followed by two washes
(5min each) in PBS. Endogenous peroxidase activity was
quenched in 2% H2O2 before exposure to TdT enzyme
at 37◦C for 60min. After washing in stop wash buﬀer
(37◦C, 30min), anti-digoxigenin-peroxidase was added (RT;
30min). AEC or DAB (ScyTek Laboratories, Inc, Logan,
UT) was used for color development, and the sections
were counterstained with hematoxylin. The numbers ofJournal of Transplantation 3
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Figure 1: Nitrite-supplemented UW solution decreased hepatic graft enzyme release. UW solution supplemented with anion nitrite
decreased hepatic graft enzyme release during 24 hours of cold ischemia. Solutions of 250 (AST—68±12; LDH—420±102) and 25 (AST—
38 ± 4; LDH—280 ± 17) µM anion nitrite resulted in the greatest reduction. Data are expressed as mean ± SE. #P<0.05 for corresponding
measurements.
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Figure 2: Nitrite-supplemented LR decreased graft enzyme release. LR supplemented with 25µM anion nitrite signiﬁcantly decreased
enzyme release at 18 hours (AST—599 ± 492 versus 178 ± 59; LDH—692 ± 269 versus 498 ± 272). Data are expressed as mean ± SE.
#P<0.05 for corresponding measurements.
apoptotic cells in liver sections were enumerated under light
microscopy by numbers of apoptotic cells per 40 high-power
ﬁelds in ﬁve sections per tissue per mouse (three mice per
group).
2.8. Caspase-3 Activity Assay. A caspase-3 ELISA kit (BD
Pharmingen, San Diego, CA) was used for in vitro determi-
nation of caspase-3 enzymatic activity in liver homogenates
d e r i v e df r o mm i c ei nd i ﬀerent groups. Brieﬂy, supernatants
were obtained from homogenized liver grafts with mam-
malian lysis buﬀer (Qiagen, Inc., Valencia, CA) including
benzonase nuclease and protease inhibitor. Flat-bottom 96-
well microtiter plates were coated with 100µL/wells of
diluted capture antibody (BD Pharmingen). Nonspeciﬁc
binding sites were blocked with blocking buﬀer. Plates were
rinsed, and standards and samples of diluted supernatant
(100µL each) were added, followed by the addition of
100µL/wellworkingdetectors(diluteddetectorantibodyand
streptavidin HRP in blocking buﬀer). After washing, the
plates were incubated for color development; the reaction
was terminated with 50µL of stopping solution. Plates were
read at 450nm in an ELISA reader. To determine the
active caspase-3 concentration of samples, computer data
reduction was employed, utilizing log-log regression analysis
in a series of diluted caspase-3 standards.
2.9. Western Blot Analysis. The antiapoptosis Bcl-2 protein
expression in the liver tissue was determined by western blot
assay. Proteins (50µg/sample) extracted from the liver tissue
in SDS-loading buﬀer (50mM Tris, pH 7.6, 10% glycerol,
1% SDS) were subjected to 12% SDS-polyacrylamide gel
electrophoresis and transferred to PVDF membrane (Bio-
Rad Laboratories, Hercules, CA). The gel was then stained
with Coomassie Blue to document protein loading. The4 Journal of Transplantation
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Figure 3: Nitrite-supplemented UW solution decreased graft enzyme release; UW solution supplemented with 25µM anion nitrite
signiﬁcantly decreased enzyme release at 48 hours (AST—221 ±.97 versus 76 ±40; LDH—991 ±420 versus 578 ±292). Data are expressed
as mean ± SE. #P<0.05 for corresponding measurements.
membrane was blocked with 5% dry milk and 0.1% Tween
20 (Bio-Rad) in PBS. The membrane was subsequently
incubated with the primary antibodies at 4◦C overnight.
The primary antibody was a mouse monoclonal antihuman
Bcl-2 antibody (Santa Cruz Biotechnology, Inc., Santa
Cruz, CA). The membranes were developed according to
the Amersham-enhanced chemiluminescence protocol. The
beta-actin was measured as a loading control.
2.10. Statistical Analysis. The comparisons were made using
Student’st-test.Probability (P)val ues≤0.05wereconsidered
statistically signiﬁcant. Data is expressed as mean ± SE.
3. Results
3.1. The Protective Eﬀects of Nitrite to Liver IRI Were Dose
Dependent. To determine if nitrite supplementation could
confer protection in the liver from cold ischemia injury,
nitrite (0.25µM–1000µM) was added to UW solution. The
livers enzymes AST and LDH were then measured from the
preservation solutions at 24 hours. In contrast to the UW
only control group, AST and LDH release was signiﬁcantly
reduced in livers supplemented with nitrite with maximal
protection observed with 25µM and 250µM nitrite (AST—
38 ± 4; LDH—280 ± 17) (Figure 1).
3.2. Nitrite Supplementation of LR or UW Solution Reduced
Liver Damage from Extended Cold Ischemia Time. We exam-
ined whether nitrite supplementation of either LR or a
preservant (UW) could protect the liver from cold ischemia
injury.B6mouseliverswereperfusedwith5mLcoldRinger’s
solution containing heparin 20 units/mL with or without
nitrite (25µM) addition. Livers were then preserved in 5mL
of the above solution on ice for 1 hour, 6 hours, and 18
hours, respectively. AST and LDH levels were tested from
the preservation solution from 3 livers pooled together in
each group. AST was detected to have a slight increase after
1 and 6 hours of cold preservation and a signiﬁcant increase
after 18 hours of cold preservation in the LR control groups.
The LDH level also increased signiﬁcantly after 18 hours of
cold preservation. Release of AST and LDH was signiﬁcantly
reduced in the nitrite-supplemented groups compared to
LRonlygroups(Figure 2).Similarly,nitritesupplementation
in the UW solution also reduced the release of liver AST
and LDH signiﬁcantly after 48 hours of cold preservation
(Figure 3).
3.3. Nitrite Supplement in LR Solution Reduced Liver Damage
from Extended Cold Ischemia Time. To examine the pro-
tective role of nitrite on hepatocytes during cold ischemia,
liver samples were harvested from na¨ ıve B6 mice without
perfusion, or from donor livers perfused and preserved
with either LR solution only or LR plus anion nitrite
supplementation at a concentration of 250µMa f t e r1h o u r ,
6 hours, and 18 hours-cold preservation, respectively. His-
tological examination on H & E staining section revealed
hepatocyte swelling, increased cytoplasmic vacuolization,
nuclear pyknosis, sinusoidal dilatation, and focal necrosis in
the LR only group after 6 hours of cold preservation, and
becoming more severe at 18 hours. In contrast, addition
of 25µM anion nitrite to the Ringer’s preservation solution
gave liver signiﬁcant protection from cold ischemia injury
during extended preservation period. The liver morphology
remained essentially normal in those groups (Figure 4).
Furthermore,livers preserved in thenitrite supplemented LR
solution demonstrated a signiﬁcant reduction of hepatocyte
apoptosis after 18 hours of cold preservation (Figure 5).
Similarly, nitrite supplementation of UW solution also
reduced liver apoptosis after both 24 and 48 hours of cold
preservation time (Figure 6).
3.4. Nitrite Modulates Caspase-3 and Bcl-2 Protein Expression.
To determine the mechanisms by which nitrite decreases
liver apoptosis under conditions of cold ischemia, caspase-3,Journal of Transplantation 5
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Figure 4: Liver pathology scores decreased with nitrite. Increased hepatocyte swelling, increased cytoplasmic vacuolization, nuclear
pyknosis, sinusoidal dilatation, and focal necrosis in LR only group with maximal injury at 18hrs are observed. These ﬁndings were
signiﬁcantly reduced at 18hrs with 25µM of anion nitrite (2.4 ± 0.8v e r s u s1 .7 ± 0.7). Data are expressed as mean ± SE. #P<0.05 for
corresponding measurements.
a cysteine protease critical for executing apoptosis, and Bcl-
2, a family of proteins demonstrated to reduce apoptosis
were measured after varying cold ischemia times (18 and 48
hours). Caspase-3 in livers supplemented with 25µM nitrite
in LR and UW solution during cold ischemia was signiﬁ-
cantly reduced at 18 (LR) and 48 hours (UW), respectively
(Figure 7). The magnitude of caspase-3 reduction between
the LR and UW preservation groups was similar (29.7 to
28.4%, resp.). Bcl-2 protein concentration determined by
western blot analysis demonstrated a signiﬁcant reduction
in both LR and UW preservation solution alone. However,
concentrations of both caspase-3 and Bcl-2 were restored
to near or back to baseline values with anion nitrite
supplementation (Figure 8).
3.5. Nitrite Reduced Liver Reperfusion Injury after Extended
Cold Preservation Time in UW Solution. To determine
whether nitrite protected livers from IRI after liver trans-
plantation, syngeneic liver transplantation from donor livers
which were either preserved in UW solution plus 250µM6 Journal of Transplantation
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Figure 5: Hepatocellular apoptosis signiﬁcantly decreased within LR-supplemented nitrite therapy. TUNEL evaluation revealed a
signiﬁcantly reduced number of hepatocellular apoptotic nuclei treated with nitrite at 18 hours (0.1 ± 0.3v e r s u s1 .7 ± 0.4v e r s u s0 .4 ± 0.5).
Data are expressed as mean ± SE. #P<0.05 for corresponding measurements.
nitrite for 12 hours or recipients that received 250µMi . p .
nitrite treatments at the time of liver transplantation was
performed. Liver enzyme release and apoptosis from the
donated livers were examined 3 hours posttransplantation.
Assessment of liver enzyme release revealed that nitrite
supplementation in the preservation solution only and
intraperitoneal treatment alone signiﬁcantly decreased ALT
and LDH release compared to the control group and the
group receiving the combined treatment of both donor
liver graft and recipient i.p. injection (Figure 9). Moreover,
nitrite treatment of the donor liver only and recipient only
signiﬁcantly reduced hepatocyte apoptosis when compared
to the control and combined treatment groups (Figure 10).
4. Discussion
Previous studies in animal models of warm IRI utilizing
nitrite as an anti-inﬂammatory therapy have demonstrated
signiﬁcant beneﬁt. In this study, we chose to supplement
solutions with varying concentrations of nitrite underJournal of Transplantation 7
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Figure 6: Nitrite reduced hepatocellular apoptosis during cold ischemia. Hepatocellular apoptosis was signiﬁcantly reduced with 250µM
of anion nitrite after 24 hours (0.2 ± 0.3v e r s u s2 .9 ± 2.2v e r s u s1 .7 ± 1.5) and 48 hours (0.2 ± 0.3v e r s u s4 .3 ± 3v e r s u s1 .8 ± 1.4) of cold
ischemia. Data are expressed as mean ± SE. #P<0.05 for corresponding measurements.
conditions of cold ischemia and to assess potential anti-
inﬂammatory eﬀects of nitrite therapy on murine hepatic
graft function. Our results show that nitrite-supplemented
solutions during cold ischemia decreased hepatocellular
injury and apoptosis during both cold ischemia and 3 hours
posttransplantation.
Previous studies have shown that nitrite dose versus
therapeutic beneﬁt exhibits a U-shaped relationship [6]. A
similar eﬃcacy proﬁle was observed with nitrite protection
against cold-ischemia-mediated liver injury with 25–250µM
aﬀording maximal protection. Previous in vivo studies
demonstrated protection against IRI injury in the liver
with <10µM nitrite concentrations [6, 12] suggesting that
liver grafts subjected to cold ischemia (compared to warm
IRI) warrant higher concentrations of nitrite as 25µM
consistently attenuated injury during cold ischemia alone,8 Journal of Transplantation
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Figure 7: Caspase-3 concentrations decreased with nitrite sup-
plemented solutions. Caspase-3 concentrations increased during
cold preservation with both LR (18 hours) and UW solutions (48
hours) alone, but were signiﬁcantly attenuated when the respective
solutions were supplemented with 250µM of anion nitrite (LR—
49.1±3.7v e rs usLR+nitrit e—38.6±3.7;UW—71.4±4v e r s u sU W
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corresponding measurements that compared groups LR and UW
only to native B6 and †P<0.05 for corresponding measurements
that compared groups LR and UW only to LR and UW groups
treated with anion nitrite.
while 250µM anion nitrite was beneﬁcial when administered
to either the graft alone or recipient animal alone in animals
3 hours posttransplantation. Attenuation of cold ischemic
injury by nitric oxide implicates the sinusoidal endothelial
cells as a principal culprit as the injury orchestrator
Hepatic enzyme release signiﬁcantly decreased when
supplemented with nitrite demonstrating a more robust
protective eﬀective eﬀect with UW compared to Ringer’s
solution as would be expected. The maximal protective eﬀect
p e a k e da t4 8h o u r sw i t ht h eu s eo fU Ws o l u t i o nc o m p a r e d
to 18 hours with Ringer’s solution. Nitrite treatment to
only the liver graft or recipient mouse was superior in
reducing hepatic enzyme release compared to combination
treatment of both graft and recipient. Interestingly, in this
seriesoflivertransplantationstudies,thesupplementationor
administration of 250µM anion nitrite was required to exert
a signiﬁcant protective eﬀect compared to 25µM used only
during cold ischemia. The mechanisms underlying why the
eﬀective doses varied by 10-fold remain unclear.
Histological injury per standardized scoring system
demonstrated reduced injury in liver grafts treated with
nitrite. The injury was maximal at 18 hours, although not
severe in either group. This observation is consistent with
previous data corroborating the fact that net and type of
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Figure 8: Nitrite-supplemented solutions mitigated reductions
in Bcl-2 concentrations. Bcl-2 protein (pooled from 3 livers per
condition)expressiondecreasedduringcoldpreservationwithboth
LR (18 hours) and UW solutions (48 hours) alone but signiﬁcantly
increased when the respective solutions were supplemented with
250µM of anion nitrite (LR—5.9±0.6 versus LR + nitrite—8.8±1;
UW—4.4±1.3versusUW+nitrite—10.8±1.1).SupplementedUW
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Data are expressed as mean ± SE. #P<0.05 for corresponding
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injury exists between cold ischemia compared to warm
ischemia [13].
Hepatocellular apoptosis decreased both with nitrite-
supplemented Ringer’s and UW solutions at 18 and 48
hours, respectively. There was less apoptosis during cold
ischemia as compared to cold ischemia plus warm ischemia
reperfusion. Nitrite treatment to only the liver graft or
recipient mouse was more eﬃcacious in reducing apoptosis
compared to combination treatment of both graft and
recipient. One possibility explaining this observation is that
the observed “protective” concentrations of nitrite may
have been exceeded leading to loss of protection per the
U-shaped dose-response relationship. Further studies are
required to determine optimal nitrite dosing and timing
strategies to prevent liver injury during cold ischemia and
posttransplantation. Liver grafts exposed to cold ischemia
displayed only decreased caspase-3 and increased Bcl-2 withJournal of Transplantation 9
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Figure 9: Nitrite administration to either the donor liver graft or recipient decreased hepatic enzyme release posttransplantation. Serum
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Figure 10: Nitrite reduced hepatocellular apoptosis in the donor liver graft and in the recipient after liver transplantation. Hepatocellular
apoptosis was signiﬁcantly reduced by anion nitrite in the donor liver graft and recipient only groups compared to control and combined
treatment groups 3 hours posttransplantation (9.8 ± 4.1v e r s u s3 .9 ± 2.4v e r s u s4 .1 ± 2.6v e r s u s7± 3.9). Data are expressed as mean ± SE.
#P<0.05 for corresponding measurements.
both Ringer’s and UW’s solutions supplemented with nitrite.
The magnitude of change in both groups while divergent was
enhanced with anion nitrite-supplemented UW solution.
Despite the study limitations that include a small sample
size, no measurements of tissue concentrations of NO, and
very short followup of the animals posttransplantation, in
aggregate, our study demonstrated a hepatoprotective eﬀect
of nitrite as evidenced by reductions in liver enzymes,
reduced pathology score, and reduced hepatocellular apop-
tosis with either LR or UW preservation solutions. The
preservation solution, UW, aﬀorded extended hepatopro-
tection compared to LR and nitrite. Liver grafts harvested
from transplanted animals were observed to have reduced
injury when only the graft or animal received nitrite
supplementation compared to both graft and animal being
supplemented with anion nitrite.10 Journal of Transplantation
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